BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Vaccinia

Below is an extended Vaccinia research listing. Click here to return to the Vaccinia main in depth entry.

Recent Publications on Vaccinia:

Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis.
Vaccinia virus (VACV), the prototype poxvirus, encodes numerous proteins...
Direct Link
16th August, 2008
The Division of Structural Biology and the Oxford Protein Production
Vaccinia virus encodes a small hydrophobic virion membrane protein (I5) that enhances replication and virulence in mice.
The vaccinia virus I5L open reading frame encodes a 79-amino acid protein,...
Direct Link
15th August, 2008
Laboratory of Viral Diseases, and Comparative Medicine Branch, National
The vaccinia virus I2L gene encodes a membrane protein with an essential role in virion entry.
The previously unstudied vaccinia I2L gene is conserved in all...
Direct Link
15th August, 2008
Department of Microbiology and Molecular Genetics, Medical College of
Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
BACKGROUND: Vaccination with a recombinant modified vaccinia Ankara...
Direct Link
14th August, 2008
Bacterial Diseases Programme, Tuberculosis Division, Medical Research
Safety and Immunologic Response of a Viral Vaccine to Prostate-Specific Antigen in Combination with Radiation Therapy when Metronomic-Dose Interleukin 2 Is Used as an Adjuvant.
PURPOSE: We have previously reported on the safety and immunologic...
Direct Link
14th August, 2008
Authors' Affiliations:Laboratory of Tumor Immunology and Biology,
Oncolytic Vaccinia Virotherapy of Anaplastic Thyroid Cancer In Vivo.
Context: Anaplastic thyroid carcinoma is a fatal disease with a median...
Direct Link
14th August, 2008
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York,
Dose-dependent lymphocyte apoptosis following respiratory infection with Vaccinia virus.
Recently there has been renewed interest in poxvirus pathogenesis,...
Direct Link
12th August, 2008
Department of Microbiology & Immunology, Wake Forest University School of
Vaccinia viral protein WR53.5/F14.5 is a new component of intracellular mature virus and is important for calcium-independent cell adhesion and vaccinia virus virulence in mice.
The vaccinia virus WR53.5L/F14.5L gene encodes a small conserved protein...
Direct Link
8th August, 2008
Institute of Molecular Biology, Academia Sinica, Taiwan, R.O.C.
IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection. 7th August, 2008
MedImmune Inc, 297 N Bernardo Ave, Mountain View, CA 94043, USA.
Oncolytic vaccinia virus: From bedside to benchtop and back. 7th August, 2008
University of Pittsburgh Cancer Institute and Division of Surgical
Virus combinations and chemotherapy for the treatment of human cancers. 7th August, 2008
University of California, San Diego, Department of Hematology and
Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1.
In clinical trials recombinant-modified vaccinia virus Ankara expressing...
Direct Link
7th August, 2008
Centre for Clinical Vaccinology and Tropical Medicine, University of
Intracranial administration of vaccinia virus complement control protein in Mo/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test.
One of the key pro-inflammatory mediators activated by amyloid protein in...
Direct Link
6th August, 2008
Division of Medical Virology, Department of Clinical Laboratory Sciences,
Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.
The success of the World Health Organization smallpox eradication program...
Direct Link
6th August, 2008
Laboratory of Viral Diseases, National Institute of Allergy and Infectious
A central role for CK1 in catalysing phosphorylation of the P53 transactivation domain at serine 20 after HHV-6B viral infection.
The tumour suppressor protein p53 is activated by distinct cellular...
Direct Link
2nd August, 2008
Cancer Biology, University of Edinburgh, Edindburgh, Scotland EH4 2XR.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional